The Department of Development Cooperation of the Netherlands Ministry of Foreign Affairs (DGIS), the leading Dutch government agency for foreign ass...
Dr. Martien Borgdorff has recently been appointed Executive Director of the KNCV Tuberculosis Foundation, a founding TB Alliance Stakeholder and lea...
“Investment in the development of new tools (diagnostics, drugs, and vaccines), followed by the rapid introduction of new tools in actual prog...
Neglected diseasesFew readers of the BMJ were probably aware or even cared that the presidency of the EU Council was held by the Dutch government duri...
New York/Amsterdam - February 3, 2005 - The Department of Development Cooperation of the Netherlands Ministry of Foreign Affairs (DGIS), the leading D...
...
JOHANNESBURG, 4 Jan 2005 (IRIN) - In the crowded wards of African hospitals, coughs and bony bodies tell the story of a deadly return. Tuberculosis (T...
Scientists are making progress on TB—again. For a disease that scientists conquered 40 years ago, tuberculosis has made an astonishing comeback....
The TB Alliance’s mission – to shorten and improve TB treatment – will ultimately rest on designing a new regimen based on entirely ...
At the 2004 annual meeting, the Stakeholders reviewed highlights of the TB Alliance’s portfolio advances and its policy and outreach activities ...
Press Contact: press@tballiance.org
Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis
New TB Regimens: What Countries Want
Pathway to Patients
Policy on the Compassionate / Emergency Use of Experimental TB Alliance Drugs